US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 2.650
  • -0.040-1.49%
Close Nov 29 13:00 ET
  • 2.790
  • +0.140+5.28%
Post 17:01 ET
218.52MMarket Cap-1709P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sutro Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.808M--
--2024/Q4-- / 12.180M--
--2024/Q38.520M / 15.257M--
--2024/Q225.706M / 21.018M--
--2024/Q113.008M / 12.073M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.808M--
--2024/Q4-- / 12.180M--
--2024/Q38.520M / 15.257M--
--2024/Q225.706M / 21.018M--
--2024/Q113.008M / 12.073M--

Unlock Free Earnings Estimates

Sutro Biopharma Earnings Reports

  • Sutro Biopharma | 10-Q: Q3 2024 Earnings Report

    Nov 13 16:39 ET

  • Sutro Biopharma | 8-K: Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 13 16:35 ET

  • Sutro Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:39 ET

  • Sutro Biopharma | 8-K: Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones

    Aug 13 16:33 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data